Destiny Hinton

Two St. Jude efforts independently uncovered the predisposition gene’s role.

See how St. Jude chemists approach drug discovery and development to make the therapies of tomorrow.

Investigate the decades-long cold case that St. Jude researchers finally cracked.

Explore the ingenuity behind therapeutic optimization

Neurosurgeon Paul Klimo, MD, explains posterior fossa syndrome, and how surgeons can work to reduce its risk.

See how combining sequencing approaches provides a ‘one-stop shop’ for diagnosing AML.

Discover how researchers find ways to improve treatments with genetic information.

The work of St. Jude Global was on display at the 80th session of the United Nations General Assembly.

St. Jude scientists are making progress in the treatment of pediatric cancer by translating new drug findings from the lab to the clinic.

Meet Andew Kleist, MD, PhD, a 2025 STAT Wunderkind early career scientist.